CME GROUP INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.5B | $6.1B | $5.6B | $5.0B | $4.7B |
| Operating income | $4.2B | $3.9B | $3.4B | $3.0B | $2.6B |
| Interest expense | $173.4M | $160.9M | $159.4M | $162.7M | $166.9M |
| Pretax income | $5.3B | $4.5B | $4.2B | $3.5B | $3.4B |
| Income tax expense | $1.3B | $1.0B | $927.4M | $799.3M | $736.7M |
| Net income | $4.1B | $3.5B | $3.2B | $2.7B | $2.6B |
| Balance Sheet | |||||
| Cash and equivalents | $4.4B | $2.9B | $2.9B | $2.7B | $2.8B |
| Current assets | $165.4B | $103.0B | $94.9B | $139.1B | $161.8B |
| Total assets | $198.4B | $137.4B | $129.7B | $174.2B | $196.8B |
| Current liabilities | $160.3B | $102.3B | $93.4B | $137.7B | $160.4B |
| Total liabilities | $169.7B | $111.0B | $103.0B | $147.3B | $169.4B |
| Stockholders' equity | $28.7B | $26.5B | $26.7B | $26.9B | $27.4B |
| Cash Flow Statement | |||||
| Cash from operations | $4.3B | $3.7B | $3.5B | $3.1B | $2.4B |
| Depreciation and amortization | $107.5M | $115.1M | $126.0M | $134.9M | $147.8M |
| Stock-based compensation | $94.8M | $89.5M | $82.9M | $84.3M | $75.2M |
| Capital expenditure | $83.5M | $94.0M | $76.4M | $89.7M | $127.2M |
| Free cash flow | $4.2B | $3.6B | $3.4B | $3.0B | $2.3B |
| Dividends paid | $3.9B | $3.6B | $3.2B | $2.6B | $2.2B |
| Impairments | — | — | — | $0 | $0 |
Shares outstanding 362.4M · Free float 82.7%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.
Recent filings
- June 17, 2026 8-K
- June 10, 2026 8-K
- May 19, 2026 8-K
- April 27, 2026 8-K
- April 24, 2026 10-Q
- April 22, 2026 8-K
- February 26, 2026 10-K
- February 4, 2026 8-K